Actively Recruiting
The Long COVID-19 Wearable Device Study
Led by Scripps Translational Science Institute · Updated on 2025-05-11
100500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying Long COVID-19 and related conditions like Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postural Orthostatic Tachycardia Syndrome to better understand symptom patterns and improve symptom management. This research involves collecting data from individuals who either already own wearable devices or are provided with one, along with educational materials. The purpose is to see if wearable devices and enhanced education can help manage symptoms, especially post-exertional malaise, which is worsening symptoms after physical activity. The study has two groups: up to 100,000 participants who already own wearable devices and will be randomized to receive different educational materials, and 500 participants without devices who will be given wearable devices and pacing education. Control groups receive basic education initially and enhanced education later, while treatment groups receive both basic and enhanced education at the start along with the wearable device. This setup allows comparison of symptom management approaches using wearable data and educational support. Participants will be asked to wear their devices throughout the study, share data weekly, and complete surveys on symptoms, quality of life, and diagnoses. Researchers will monitor sensor data like sleep, heart rate, activity, and body energy levels over 12 months. The main outcomes include assessing symptom severity changes at 3 months and collecting a detailed dataset over a year. Participants may also disclose other treatments they are using. The total duration and data collection aim to improve understanding and management of Long COVID and related symptoms.
CONDITIONS
Brief Title
The Long COVID-19 Wearable Device Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Is at least 18 years old.
- Has a self or physician diagnosis of Long COVID, ME/CFS, or POTS.
- Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
- Owns a wearable device they are willing to use or agrees to use a study-provided wearable.
- Agrees to wear the device throughout the study and share data at least weekly.
- Has access to a smartphone or tablet to sync wearable data and view feedback.
- Agrees to disclose involvement in other related treatments or studies.
- Agrees to complete at least 75% of study surveys.
You will not qualify if you...
- No exclusion criteria if inclusion criteria are met.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 12 months
Participants receive a wearable device and educational materials to help manage Long COVID-19 symptoms. Some participants will receive the device and enhanced education at the start, while others will receive it after 3 months.
Regular data sharing at least weekly and periodic survey completions
Trial Site Locations
Total: 1 location
1
Scripps Research
La Jolla, California, United States, 92037
Actively Recruiting
Research Team
A
Andrea Goosen
R
Romina Foster-Bonds
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here